William King (Will King)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Urinary Tract Infection

Placebo Controlled

Quality Improvement

Top Venues

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

William King, Tara Homer, Chris Harding, Helen Mossop, Thomas Chadwick, Alaa Abouhajar, Luke Vale
Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial. BMJ open 14 (4) (2024)
William King, Tara Homer, Chris Harding, Helen Mossop, Thomas Chadwick, Alaa Abouhajar, Luke Vale
Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial. BMJ open 14 (4) (2024)
William King, Tara Homer, Chris Harding, Helen Mossop, Thomas Chadwick, Alaa Abouhajar, Luke Vale
Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial. BMJ open 14 (4) (2024)
William King, Tara Homer, Chris Harding, Helen Mossop, Thomas Chadwick, Alaa Abouhajar, Luke Vale
Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial. BMJ open 14 (4) (2024)
Christopher Harding, Thomas Chadwick, Tara Homer, Jan Lecouturier, Helen Mossop, Sonya Carnell, William King, Alaa Abouhajar, Luke Vale, Gillian C Watson, Rebecca Forbes, Stephanie Currer, Robert Pickard, Ian Eardley, Ian Pearce, Nikesh Thiruchelvam, Karen L Guerrero, Katherine Walton, Zahid Hussain, Henry Lazarowicz, Ased Ali
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health technology assessment (Winchester, England) 26 (23) (2022)